Aims: To test the hypothesis that weight regain is partially attributable to poor compliance due to poor palatability and culinary pleasure of traditional fat-reduced cuisine. Methods: In all, 56 obese patients of both genders were enrolled in a controlled 12-week trial consisting of energy-restricted diet in combination with orlistat 120 mg/day. Patients achieving at least 8% weight loss subsequently received dietary treatment and were randomised to either 5 months behaviour modifi cation based on neuro-linguistic programming (NLP) or a course, of similar duration and time use, in pleasure-motivated gastronomic cookery, based on concepts adapted from the Indo-Mediterranean kitchens, followed-up after 1, 1½, 2 and 3 years. Results were analysed on the intention-to-treat model. Results: Of the 56 subjects, 49 (88%) completed the initial weight-loss phase and lost 8% of initial body weight, and were included in the subsequent randomisation. The NLP group lost 0.5 kg during the 5 months weight-maintenance treatment and the cookery group lost 0.1 kg (ns), but drop-out rate in the cookery group was only 1 in 25 (4%) versus 6 in 23 (26%) in the NLP group (Odds Ratio: 8.5 (0.9-76.9), P=0.03). There was no difference in weight maintenance at follow-up at 3 years; 56% in the NLP group and 44% in the cooking group had maintained some of the weight loss. Conclusion: Weight loss is maintained to a similar extent by a cookery course or by behaviour modifi cation, but with a lower drop-out rate. 
T5:P5a-003 MEANS WHICH ARE USED FOR WEIGHT LOSS BY 1000 OVERWEIGHT OR OBESE SUBJECT

subjects (OBS).
Methods: An investigation was performed upon 1000 OWS and OBS, aged 18-70 years, from a sample survey by phone. Results: 75,8% of the total subjects (TS) are OWS and 24,2 % are OBS. 76 % of the OWS (Male (M) 68,9%; Female (F) 81,2 %) and 85 % of the OBS (M 77 % ; F 90 %) have already felt the need to lose weight. 66 % of the OWS and 83 % of the OBS have already tried to reduce their weight intentionally. During these attempts, 79 % of the subjects have begun a restrictive diet and 65 % have practised physical activity (less often if the BMI is higher, and males more often than females), from their own initiative. Among those who have already tried to lose weight intentionally, 49 % have taken medical (general practioner > specialist) or dietetician advice (more often if the BMI is higher, and females more often than males). 63 % of the TS (OWS 58,9 %, OBS 76 %) have followed at least one restrictive diet during their life. Among them, 57 % have diffi culties to follow it, 47 % have a tendency to stop it prematurely, 26 % consider that dieting do not work for them (more often if BMI is higher, and if they have already asked for medical advice, for each item). 37 % know that drug treatment for weight loss exists and only 12 % of the total subjects would consider using such medications. Conclusions: Attempts for weight loss concern a lot of OWS and OBS. Most of the subjects have already followed a restrictive diet, but they often meet diffi culties. Only few would consider to use a drug treatment. Means which are used seem to be in discrepancy with the frequent need to lose weight in OWS and OBS.
T5:P5a-004 DIFFERENCES IN PHYSICAL, EMOTIONAL AND SOCIAL FACTORS WITH WEIGHT CHANGE IN ADULTS SEEKING TREAMENT FOR THEIR OBESITY
Brown Jenny 1 , Wimpenny Pete
Introduction: Reduction in ventilation function is one of the consequences of obesity, and hypoxia could contribute to insulin resistance. Fasting high level of Respiratory Quotient (QR) could contribute to weight gain, due to low level or lipid/carbohydrate oxidation ratio. According to these fi ndings, a reduction of this oxygenation defi cit in obese subjects could improve treatment results. Methods: After the previous observation of a reduced QR in 40 women using respiratory integration with therpenic compounds alpha and beta and peroxidate by technological procedure (Holiste, France) in comparison with 40 controls, we tested 16 subjects (14 F e 2 M), age 45.1 + 7.7 years, BMI 36.6 + 10.3 kg/m 2 and QR 0.97 + 0.09 on balanced diet (defi cit of approximately 500 kcal). Subjects performed 9 min. per day of respiratory integration (3 -5 times/week) for two months and we evaluated metabolic (indirect calorimeter) and body composition (anthropometrics) changes. Results: Subjects after the treatment period showed 4.1 kg weight reduction on average; highly signifi cant reduction of QR (p=.0001) and VCO 2 (p=.01); an increase of arm circumference (p=.0001), and VO 2 (p=.007) and a signifi cant positive correlation between increasing of arm circumferences and VO 2 (r=0.69, p=.003). Conclusions: Respiratory integration using the device designed by Réné Jacquier improved oxygen biodisponibility at the tissue level and promoted lipid oxidation. These fi ndings could introduce with success an additional new tool in obesity managing, improving other treatments. Aims: To determine the accuracy of weighing procedures within a UK general hospital. Methods: A total of 53 patients (30M, 23F) attending 10 specialist outpatient clinics (Gastroenterology, Respiratory, Lipid, Cardiology, Rheumatology, Diabetes and General Surgery) underwent a measure of body mass, using specifi c calibrated scales by a trained nurse following WHO guidelines (RBM). This measure was then compared to body mass, if recorded by outpatient clinic staff (CBM). Hospital policy states that all out-patient attendees should be weighed. Results: Of the 53 patients approached, only 6 had a clinic height recorded; 20 had no CBM recorded (none attending Cardiology or General Surgery clinics). RBM of these patients was 30 (22.4, 42 
T5:P5a-009 WEIGHING IT UP -THE ACCURACY OF RECORDING WEIGHT WITHIN A UK GENERAL HOSPITAL
kg).
Conclusions: Body weight assessment and treatment of overweight or obesity is integral to medical care; yet, even in this specialist care setting, less than two-thirds of patients had a body mass measured. Due to the infrequency of height measurements, BMI could only be calculated in 11% of patients. When weight was measured, it was done so with accuracy (error compared to RBM <4%), although there was a small positive bias for CBM. There is a persisting failure of clinicians to include body mass as part of their evaluation (and therefore presumably management) of their patients.
T5:P5a-010 METABOLIC BENEFITS OF A REGULAR MEAL PATTERN IN HEALTHY OBESE WOMEN
Farshchi Hamid R, Taylor Moira A, Macdonald Ian A School of Biomedical Sciences, University of Nottingham, Notttingham, UK Aims: To investigate the impact of a regular meal frequency on plasma insulin, glucose and lipid concentrations and energy intake (EI) and energy expenditure in healthy obese women. Methods: 10 obese women (BMI: 37.1, SD: 4.8), 32-47 yr., participated in a randomised cross-over trial. In Phase 1 (14 days), subjects consumed their normal diet on either 6 occasions per day (regular) or by following a variable meal frequency (3-9 meals/day, irregular). In Phase 2 (14 days), subjects followed the alternative meal pattern. After an overnight fast at the start and end of each phase, blood samples were taken for glucose, lipids and insulin measurements before and for 3 hr after a high-carbohydrate test meal. Subjects recorded their food intake during the 2 interventions on 3 days. Resting energy expenditure was measured by indirect calorimetry before and after the test meal. Results: Regular eating was associated with lower fasting total (P<0.01) and LDL (P<0.02) cholesterol. Fasting glucose and insulin values were not affected by meal pattern, but peak insulin and AUC of insulin responses to the test meal were lower after the regular compared with the irregular meal pattern (P<0.01 & 0.02, respectively). Mean EI was lower for the regular meal pattern (P<0.01), while postprandial thermogenesis was greater after the regular meal pattern (P<0.01). Conclusion: A regular meal pattern appears to produce more appropriate insulin and lipids profi les and improve dietary thermogenesis. Background: Patients on dietary, weight-reducing treatment are commonly advised against alcohol consumption. In light of the widespread use of alcohol and the well-established benefi ts of moderate alcohol consumption in risk reduction, a revision of dietary treatment recommendations may be warranted. Objective: To investigate whether daily consumption of moderate amounts of alcohol infl uences the effectiveness of an energy-restricted diet. Design: A prospective randomized clinical trial was conducted, with a 3-months intervention with two diets containing 6.3 MJ (1500 Kcal) each, one with 10% of energy from white wine (WW) and one with 10% of energy from grape juice (GJ). Out of 87 patients, 49 were eligible to participate and 40 completed the study (age 48.1±11.4 years, BMI 34.2±6.4 kg/m 2 ). Results: All subjects achieved signifi cant body weight reduction. Weight loss in the GJ group and WW group was 3.75±0.46 kg and 4.73±0.53 kg, respectively. Percent body fat, waist circumference, blood pressure, blood glucose, insulin, triglycerides, and cholesterol were reduced with no signifi cant differences between the groups. Conclusions: An energy-restricted diet is effective in overweight and obese subjects used to drinking moderate amounts of alcohol. A diet with 10 % of energy derived from white wine is as effective as an isocaloric diet with 10 % of energy derived from grape juice. Aims: The purpose of this study was to analyze the weight goals of overweight and obese patients seeking treatment to reduce their weight. Methods: We considered 303 unselected subjects consecutively evaluated in our outpatient obesity clinic in Pavia, Italy. There were 209 women (mean age ± sd : 41.0 ± 14.7) and 75 men (mean age ± sd :40.8 ± 12.7) who spontaneously decided to initiate a weight-loss program under medical supervision in a University setting. Most of them (46.7 %) were obese, OB(Body Mass Index, BMI > 30), 39 % were overweight, OW (BMI 25 -29.9) and 13 % were normal weight, NW subjects. During the initial assessment, they were specifi cally asked how much weight they want to lose and the results were correlated with their initial weight and BMI. Results: The desired weight loss averaged 21% of initial body weight in overweight and obese subjects. The percentage of desirable weight loss varied across BMI ranges as follows: NW : 11.3% ±4.1; OW: 14.2±6.1; OB Ist grade 18.4±7.4; OB IInd grade 22.9±8.8; OB IIIrd grade 28.2±13.2. Conclusions: In our study, overweight and obese subjects show a high consciousness of their excessive weight. This is demonstrated by the higher amount of weight loss desired by the fatter subjects. However, patients' expectations are in contrast to professional recommendations, which suggest that obese people seek modest reductions (5 -10%) in body weight rather than striving for "ideal weight". 42.7± 12.0). Additional group counselling (20 weeks) was added to a conventional obesity-SBT programme during the second semester. The between-arms difference was group-counselling intensity: meeting volume (10 vs 5 meetings), frequency (2 vs 4 week interval), duration (120 vs 60 min), and size (8 vs 16 participants) -a resource ratio of 4:1. Steps·day -1 were reported in ten 7-day activity diaries every other week during the second semester. Intention-to-treat analysis was used. Results: Drop-out was 25.2% at the end of the second semester (11 in the high-intensity group and 6 in the low-intensity group, p=0.087). During the 20 weeks, the high-intensity group on average walked 9001 steps·day -1 (95% CI: 7896-10106). The corresponding fi gure for the low-intensity group was 6606 steps·day -1 (5569-7644) (F 10.8, p<0.002). Weight loss was 9.5 kg (7.2-11.8) in the high-intensity group, and 8.2 kg in the low-intensity group (5.0-11.4) (F 2.7, p<0.109) .
T5
T5:P5a-013 EFFECT OF ORLISTAT ON THE BODY FAT MASS AND LEAN BODY MASS IN THE TREATMENT OF OBESITY
Conclusions:
The data suggest that group-counselling intensity infl uences walking adoption in severely obese adults. The betweengroup difference in walking volume was insuffi cient to generate a difference in weight loss. Results: The analyses of the received data revealed that from 4219 patients-1173 (28%) had thyroid gland pathology; in 365 cases (31%) there were structural changes like hyperplasia of the I degree and single colloid inclusions. In 129 patients (11%) we determined the nodule in thyroid gland and they underwent an operation; in 243 subjects (20,6%) the diagnosis of hypothyroidism and in 436 patients (37,4%) the autoimmune thyreopathy was defi ned based on results of ultrasound and the thyroid gland hormones.
T5
Conclusions:
The obese patients with structural changes of thyroid gland (31%) and without any changes in hormonal analyses received only the low-calorie diet, and during this period the structural changes in thyroid gland regressed; the second part of the obese patients with structure-functional alterations of the thyroid gland (58%) together with the low-calorie diet received in the individual doses levothyroxine sodium. Results: Of the 1091 subjects, 411 themselves (37.7%) perceived as obese, 184 (16.9%) subjects had ever attempted to lose weight, 101 (9.3%) subjects reported to be trying to lose weight. Among the 101 respondents who were trying to lose weight, the expected weight loss was 8.5kg in a 52-day period on average. Diet control (79.9%) and exercise (65.8%) were the two most common weight-loss methods. Out of the 184 subjects who attempted to lose weight, 53.2% had tried alternative methods for weight loss and 30.4% of them had ever used anti-obesity drugs. Using the multiple logistic regression model, female or self-perceived obese subjects were more likely to exhibit weight-loss behavior favoring anti-obesity drugs. Conclusions: The discrepant weight perception and ineffi cient weightloss behavior are not uncommon in Taiwan. It is prudent to educate healthy weight-loss strategies and ameliorate the possible epidemic problem of obesity in the near future.
T5:P5a-020 THE CHANGES IN RADIAL ARTERY PULSE WAVES BY AURICULAR STOMACH POINT DETECTION AFTER RAPID WEIGHT LOSS. DIGITAL AND FREQUENCY ANALTSIS.
Ikezono Etsutaro, Ikezono Tomiko, Takahashi Gentaro New Obesity Research, Suginamiku, Japan Aims: Non-invasive digital analysis of radial pulse waves was performed following the detection of auricular acupuncture stomach point, before and after the rapid weight loss of 18±5 kg in 5.7±1.8 months.
Methods: Four males and three females with an average BMI=31.6±1.3 were treated by a low-caloric diet therapy of 4.6 MJ, with enhancing satiation by ear acupuncture of stomach point, detected by Agiscop DT. Radial artery pressure waves were measured by tonometry and digital analysis such as systolic pressure and peak-to-peak intervals were performed. Frequency analysis of p-p intervals, high frequency (HF, 0.15-0.4 Hz) and low frequency (LF, 0.04-0.15 Hz) were analyzed. Results: 7 patients lost a weight of 14.3-28.9 kg in 4-9 months. Prior to the treatment, radial artery tonometry revealed an increase in systolic pressure from 114.8±9.8mmHg to 126.1±10.5mmHg (p=0.0028), and decrease in peak-to-peak interval from 971.9±142.2 msec to 937.7±120.8 msec (p=0.0232), following the detection of the stomach point. On the contrary, after rapid weight loss, these changes were not signifi cant. Neither HF (parasympathtic) nor LF/HF (sympathetic) ratio has changed, prior to or after the weight loss.
Conclusions:
The changes in radial artery pulse waves by stomach point detection, prior to the treatment, seem not related to pulse rate variability.
T5:P5a-021 COMPARISION OF TREATMENT OF ADIPOSITY BY DIFFERENT METHODS.
Ivanova Lioudmila A. Kuban Medical Academy, Krasnodar, Russia Aims: To compare the effi ciency of treatment with a diet, physical activity; with a diet, physical activity, Orlistat; with a diet, physical activity, Orlistat, Metformin. Methods: A total of 62 patients, 34-56 years, with adiposity have been divided into 3 groups: I -20 persons were treated with a diet, physical activity; II -21 persons -a diet, physical activity, Orlistat (3 months); III -21 persons -a diet, physical activity, Orlistat, Metformin (3 months) with subsequent transition to a diet, physical activity (I, II) and Metformin (III). All patients received high-protein, hypolipidemic diet. A weight, body mass index (BMI), waist circumference (WC), appetite, a carbohydrate and lipid metabolism, blood pressure (BP), HOMA-IR, and oral glucose tolerance test (OGTT) were measured initially and at 3 and 12 months. Results: At 3 months, more expressed positive dynamics was marked in groups II, III in comparison with I, with a valid difference of weight, BMI, WC, of cholesterol, triglyceride levels, number of food intakes without a valid difference between group II and III. The valid decrease in BP was found in all the 3 groups. In group III, HOMA-IR decreased (p<0.05), in group I, II HOMA-IR was not reduced. In 12 months, 60, 80, 100% of patients had stable weight in groups I, II, III. OGTT changed up to normal in groups I, II, III by 36, 72, and 97%. There was an increase of HOMA-IR in group I in comparison with the data at 3 months, HOMA-IR did not change in group II, this parameter decreased in group III (p<0,05). Conclusions: Treatment of adiposity with a diet, physical activity, Orlistat, Metformin in comparison with a diet, physical activity, Orlistat within 3 months has no advantages concerning weight reduction, but it is preferable because of more signifi cant reduction of insulin resistance, weight and appetite.
T5:P5a-022 INTERNET-BASED WEIGHT-LOSS PROGRAMS, A SWEDISH APPROACH
Jonasson Josefi ne, Hyll Mary, Linné Yvonne, Rössner Stephan Obesity Unit, Karolinska University Hospital, Huddinge, Stockholm, Sweden Aims: To create an internet-based weight club (IW) to reach the Swedish overweight and obese population at large. Methods: Standard algorithms for calculating BMI, food energy content, exercise cost and energy balance, etc. were introduced on a website. The members could interact with professional weight-loss staff in different ways. They received weekly recipes, recipe modifi cation opportunities, exercise suggestions and exercise (pedometers etc) or cooking tools at reduced prices. Security cutoff rules were included to minimize the risk of subjects with eating problems or disease to join the club. Basic questions, taken from the standard questionnaire of our obesity unit, were included to form a database for scientifi c evaluation. Treatment success, attrition and use of the various components of the program can now be monitored on line onwards. Data presented are from the fi rst 5984 subjects, who have been in the program for 3 months. Results: At the beginning, the subjects had a BMI of 29.9 ±5.2 kg/m 2 , 84.3% had BMI >25. On average, the members have entered the weight club 63 ±78 times and they reported their weight 7 ±5 times. They lost an average of 1.9 ±2.7 kg. The subjects with BMI >25 lost most weight, but they used the program less often than the more normal weight group. Conclusions: An IW seems to be an effi cient alternative to those who cannot get help from other support systems. With an IW, it is possible to treat numerous subjects extremely cost-effectively. The database will provide a unique opportunity to evaluate factors of importance for maintained weight loss. Aims: To determine the effect of sibutramine treatment on blood pressure in obese subjects with different degrees of hypertension (normotension, grade 1 and 2 hypertension, isolated systolic hypertension (ISH)). Methods: Meta-analysis of two clinical trials with 1336 pat. Results: Sibutramine reduced body weight regardless of basal blood pressure. In the complete set of patients, systolic blood pressure did not change with either intervention over a 48-week period (-0.1±15.5 mmHg with sibutramine, -0.2±15.2 mmHg with placebo, p=0.9). The change in diastolic blood pressure was 0.3±9.5 mmHg with sibutramine and -0.8±9.2 with placebo (p=0.049). The blood pressure response was not exacerbated in patients with grade 1 or grade 2 hypertension or in patients with ISH. Blood pressure changed to -2.8±15/-4.5± 9.8 mmHg with sibutramine and -1.4±14/-5.7±9 mmHg with placebo, -7.7±15/-4.2±9.2 mmHg and -11±22/-6.6±12 mmHg, -8.1±13/1.9±8.7 and -5±15/0.5±6.9 mmHg in patients with grade 1 and 2 hypertension and with ISH, respectively. Conclusions: Sibutramine treatment is unlikely to elicit a major increase in blood pressure even in hypertensive patients. However, blood pressure and heart rate should be monitored closely.
T5:P5a-023 INFLUENCE OF SIBUTRAMINE ON BLOOD PRESSURE: EVIDENCE FROM TWO PLACEBO-CONTROLLED TRIALS WITH HYPERTENSIVE OBESE PATIENTS IN GERMANY
T5:P5a-024 ASSOCIATION OF CHANGES IN MACRONUTRIENT AND CALCIUM INTAKES WITH BODY WEIGHT CHANGE IN OBESE SUBJECTS
Kabrnova K., Braunerova R., Aldhoon B., Hlavaty P., Wagenknecht M., Kunesova M., Parizkova J., Hainer V. Obesity Management Ctr., Endocrine Institute, Prague, Czech Republic Aims: To evaluate the association between body weight change and change in the consumption of macronutrients, calcium and phosphorus in response to the weight-reduction regime. Methods: Two hundred and eight obese subjects (BMI: 40.0+7.6, body weight: 112.8+25.6, age: 46.7+12.3) were followed during the weight management lasting 3-6 months. Patients were prescribed a diet with a 500 kcal daily defi cit related to calculated total energy expenditure, half an hour daily walking and regular dietary records and monthly check-ups by dietician. Energy and nutrient intake was evaluated from a one-week food record utilizing the PC programme. Nutrition intake was both at the beginning and at the end of weight-reduction regime. Partial correlations between the change in body weight and change in nutrient intake were calculated. Results: Change in body weight was positively related to the change in fat intake (r = 0.220, p = 0.002) and phosphorus intake (r = 0.195, p = 0.006) and negatively related to the change in protein intake (r = -0.289, p = 0.000) and calcium intake (r = -0.210, p = 0.003). On the other hand, no signifi cant association with the change in carbohydrate intake and change in body weight was observed. Conclusion: In contrast to the change in fat intake, changes in protein and calcium consumption are inversely related to body weight change in response to the negative energy balance. Aims: To assess sleep apnea symptoms and health-related quality of life during and after weight loss in patients with sleep apnea using patients without sleep apnea as a control group. Methods: The sample included 11 patients with (S group) and 53 without (N group) sleep apnea. The mean BMI was 43 in S and 42 in N. The weight-loss program included 4 months of weekly group visits with initial 10 weeks on VLED. Daytime sleepiness was measured by Epworth Sleepiness Scale (ESS), quality of life by Obesity-related Psychosocial problems scale (OP). Weight, ESS, and OP were measured at baseline, 4 months, and at 1 and 2 y after the end of weight-loss program.
Results: At 4 months, the mean+/-sem weight change was -9.9(1.7)% in S and -13.2(0.8) in N, and at 2 years -5.1(2.3) in S and -2.0(1.1) in N (p=0.05). There were no between-groups differences in weight-loss success (proportion of those with 5% or more maintained weight loss). The mean+-sd ESS score at baseline was 11.7(2.7) in S and 4.1(2.7) in N. In sleep apnea group at 4 months, the score decreased to 7.8(4.0), and at 2 years the score was still at a reduced level 6.2(3.6). The score did not change in N (p<0.001 between groups). At baseline, the score for OP was similar in both groups (67.1(20.8) in S and 59.6(26.6) in N, ns). At 4 months, the OP score decreased in both groups (11.8(9.3) in S and 17.8(3.8) in N, p<0.001). The scores remained at a lower level in both groups for the 2-year follow-up.
Conclusions: Weight loss is associated with long-term improvements in daytime sleepiness and obesity-related psychosocial problems among obese sleep apnea patients. Aims: To review the evidence from randomised controlled trials on the use of low glycaemic index diets in the management of CHD. Methods: The Cochrane Library, MEDLINE, EMBASE, CINAHL, were searched. All randomised controlled trials and controlled clinical trials, of four weeks or longer, in which a low glycaemic index diet was the main intervention, in adults with at least one major risk factor for CHD, or with diagnosed CHD, were included. Results: Fifteen studies (from 17 papers) were identifi ed. Many of these studies were short term with small sample sizes. The review did show a weak but signifi cant relationship between low glycaemic index diets and lower total cholesterol, HBa1c and insulin, compared with control diets. Also, most of the other risk factors, apart from HDL cholesterol, were improved in those on a low glycaemic index diet. Conclusions: Current evidence suggests that low glycaemic index diets may offer a small advantage in the management of CHD. There is a need for properly powered, randomised controlled trials using standard methodology over periods of time longer than 4 weeks that assess the usefulness of low glycaemic index diets in the management of CHD. The review is expected to be published in The Cochrane Library in 2004. Aims: Many studies have shown WHR to be directly related to LDL-c and inversely related to serum HDL-c in the serum. It has also been shown that serum lipid levels have a stronger relationship to WHR than to body mass index (BMI). Abdominal fat and high WHR are known as coronary risk factors. This study, therefore, was conducted to examine the effect of weight reduction on abdominal fat and WHR. Methods: 83 women, 20 to 45 years old, referring to our private clinic were surveyed on the fi rst visit and 30 to 45 days later. Height, weight, waist and hip circumference were measured and WHR as well as BMI were calculated. Pearson and linear tests were employed. Results: The mean age was 30±7.7 years, height 159.9±6.3 cm, weight 79.3±12.7, BMI 31.1±4.9, waist 91.9±9.3, hip 114.5±9.8 and WHR 0.8±0.06. The mean energy intake was 1028+112kcal. At the end of the study, signifi cant reduction was observed in weight, waist and hip circumferences, but WHR reduction was not signifi cant. Pearson regression test showed the relationship of weight reduction to original weight to be signifi cant (r=0.27). Waist reduction was related to reductions in weight (r=0.6), WHR (r=0.66) and hip circumference (r=0.36, p<0.01). Analyzing the BMI decreases revealed BMI effect on hip reductions. Conclusion: Short-term dieting had a signifi cant effect on waist and hip circumferences, which could be preventive in cardiovascular disease. More studies are needed on a larger number of samples to arrive at defi nitive conclusions. Aims: To identify/compare clinical parameters characterising the PCOS-associated obesity before and after pharmacological (metformin) and non-pharmacological (behavioural-) treatment. Methods: A total of 45 Caucasian PCOS women (with oligo-ovulation, hyperandrogenism, FSH/LH ratio>1), normal in TSH-, f-T3-levels, renal/liver function were randomised. On top of 5 behavioural therapy sessions, 20 placebo-and 18 metformin-(1.5 g/d) treated patients were prospectively investigated at baseline, 2, 4 months after treatment start. The assessment includes: body mass index; waist-to-hip-ratio; blood pressure; heart rate; metabolic parameters; sexual hormones; energy/fat intake. a = between start vs. 4 months metformin group Aims: The aim of the study was to investigate the effect of a low-carbohydrate (CHO), ad libitum diet on body weight and insulin sensitivity indicators in mildly obese adults. Methods: Eleven males and 13 females, age 24±0.7, body fat 29±1.4%, were tested before and after 14 days on a low CHO diet. Food diaries (3-d) and fasting blood samples for insulin sensitivity index (HOMA) and negatively associated with insulin sensitivity plasma NEFA, phospholipid (PL) FA (SFA, MUFA and PUFA) and triglycerols (TG) were collected before and after the diet. Results: Daily caloric intake on the diet was reduced by 37%. CHO intake decreased from 48% to 7% and protein increased from 16% to 34% total kcal/day. The dietary contribution of fat increased from 36% to 59% total kcal/day; however, absolute fat intake did not differ (106±14 vs. 99.6±7.7 g/day) and % contribution of MUFA, PUFA and SFA remained unchanged on the diet. Aims: The weight gain is a common side-effect of psychiatric drugs. We investigated patients' weight and weight reduction in relation to the nature of their psychiatric medication and the diagnosis. Methods: The weight-reduction group has been meeting under the counselling of a psychiatrist and a nutritional therapist. The criteria for inclusion in the group have been obesity, desire to lose weight and some kind of mental problem apart from obesity. The group has been meeting at 1-3 week intervals at set times. The group has had a skeleton programme on various topics related to eating and nutrition. Results: A total of 81.2% of the participants were women. The mean age was over 40 years. In all, 56.2% have BMI over 35 and 55,4% of the patients were schizophrenic. Many patients use several drugs. Main categories were classic neuroleptics (27.4%), modern neuroleptics (17.1%), modern antidepressants (15.5%). In total, 40.6% of the participants lost weight during the group. Conclusions: The participants in this group were very ill and they used many drugs. In this study, the use of usual methods was very problematic. There is very much to be done in this fi eld. Aims: A pilot study comparing the effect of n-3 PUFA added to very lowcalorie diet (VLCD) with VLCD on weight loss, body fat distribution and markers of oxidative stress in severely obese women. Methods: In all, 14 severely obese women were randomly assigned to VLCD or VLCD with n-3 fatty acid supplement (n-3VLCD). The regimen was maintained for 3 weeks in in-patient setting. The groups did not differ in weight (VLCD 106.9±11.7; n-3 VLCD 108.8±10.4kg), BMI (41.79 ±3.85; 41.46 ±5.74 ) and age (54.25±14.1;56.17±4,62yr).Markers of oxidative stress were assessed (malonyldialdehyde, superoxide dismutase activity in erythrocytes, alpha-tocopherol and ascorbic acid). Results: Weight loss tended to be higher in the n-3VLCD group, hip circumference decreased more after n-3VLCD (5.2±2.1cm) than after VLCD (2.7±2.0cm), p<0.05. No differences in markers of oxidative stress were revealed. Conclusions: Higher hip circumference loss and trend to higher weight loss after weight-reducing regimen consisting of VLCD and n-3 PUFA in comparison with VLCD alone suggests a positive effect of n-3 PUFA in weight reduction. 
T5:P5a-026 A COCHRANE SYSTEMATIC REVIEW OF LOW GLYCAEMIC DIETS FOR CORONARY HEART DISEASE
T5:P5a-028 CHARITÉ ADIPOSE POLYCYSTIC OVARY SYNDROME-STUDY -GREATER WEIGHT REDUCTION IN METFORMIN-TREATED LESS HEAVIER PCOS-WOMEN
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Aims:
To examine the effect of a snacking intervention strategy on energy, total fat and saturated fat intake. Methods: A total of 38 normal-weight, habitual snackers (19M, 19F) completed a study examining the ability of 4 types of snacks varying in nutrient (low fat, LF or high fat, HF) and sensory properties (Sweet, SW or non-sweet, NSW) to infl uence appetite control and adjust daily energy (EI), total fat (TFI) and saturated fat intake (SFI). Subjects consumed each snack type for 3 weeks and ate a minimum number of snacks so that at least 25% of daily EI came from snacks. EI, FI and SFI from the snacks were directly calculated every day and also indirectly from other eating episodes (3-day food diary). Results: Daily EI did not differ signifi cantly during exposure to any of the 4 snack types (EI reduced by 0.34MJ/day during LF periods). Different levels of snack consumption were therefore largely compensated for by EI from the rest of the diet. In addition, daily EI during the study did not differ from that pre-study. On average, consumption of LF snacks reduced the percentage of daily EI consumed as F (%E as F) from 38 to 33 % (p<0.01), reduced TFI from 110.6 to 90.3g/d (p<0.01) and reduced SFI from 37.9g/day to 33.4g/day (p<0.01). HF snacks increased % E as F, TFI and SFI. Conclusions: In habitual snackers, unlimited consumption of LF snacks, compared to HF snacks, is an effective strategy to reduce TFI and SFI, so that they approach the recommendations of dietary guidelines without increasing daily EI. Aims: Is there signifi cant lowering of total cholesterol and/or LDL-cholesterol in hypercholesterolemic overweight/obese patients who received orlistat+diet compared to placebo+diet? What is the tolerability of orlistat to these subjects? Methods: Randomized, double-blind, placebo-controlled, parallel,multicenter study,with 586 patients, M/F,18-65 years old; BMI > 25;with cholesterol ≥ 6.21 mmol/L and/ or LDL ≥ 3.36 mmol/L. Patients were randomized to orlistat (n=286) or placebo (n=300) tid po for 3 months, and advised AHA step I diet, keep a food diary, 30-minute daily walking, and clinic visits at 4-week intervals. Intent-to-treat analysis was performed. Results: Demographics, clinical data, weight, BMI, cholesterol and lipid profi le, compliance to clinic visits, drug intake, exercise, and submission of diet diaries were comparable in both groups. Orlistat subjects had signifi cantly greater reduction of body weight (p=0.001) and cholesterol/ LDL blood levels (p<0.001). Total cholesterol and LDL decreased by 0.066 mmol/L and 0.058 mmol/L,respectively for every 1-kg body weight lost due to orlistat. Reduction in cholesterol and LDL from baseline to 12th week remained signifi cantly greater in the orlistat group after adjusting for percentage of weight loss. The orlistat group (61%) had more adverse events (AE) than the placebo group (19%). Fatty/ oily evacuation, fl atus with discharge, and fecal urgency were the most common AE in both groups. Conclusion: Orlistat + diet compared to diet alone signifi cantly decreases blood cholesterol, LDL, and body weight among Filipino overweight/ obese patients. Reduction in cholesterol and LDL is independent of weight loss. Aim: To compare two isocaloric meals containing different dietary protein-to-fat ratios on glycemic control, energy expenditure and appetite, before and after weight loss in overweight men and women with hyperinsulinemia. Methods: Two groups of subjects (25 men/ 32 women, aged (mean ± SD) 50 ± 10 yrs, BMI 33.8 ± 3.4 kg/m 2 , fasting insulin 18.8 ± 6.4 mU/L) were randomly assigned to either a higher protein (HP) (34% protein, 29% fat) or a high fat (HF) (18% protein, 45% fat) diet in a parallel, clinical intervention study of 12 wks energy restriction (6 MJ/day) and 4 wks energy balance (7.4 MJ/day). Results: After 16 wks, weight loss (~10%) was similar in the HP and HF groups. Following weight loss, TEF was greater in the HP than HF group (6.9 vs 4.3%, p=0.014). The glucose and insulin responses to the test meals were reduced similarly in both diet groups (p<0.001). At both wks 0 and 16, the subjects desired less to eat over the 3-hour period following the HP than the HF meal (p=0.02). After 12 months, the weight loss was 7.7 ± 1.9% on the SP diet and 5.2 ± 1.5% (or 4.7 ± 1.5 kg) on the HP diet (NS). Conclusion: Although weight loss with these isocaloric diets was similar over 16 wks, the HP meal elicited a greater TEF and reduced the amount of food desired at the next meal, but neither dietary pattern conferred any benefi t when prescribed ab-libitum over 12 months.
T5:P5a-034 EFFECTS OF MEALS WITH AN INCREASED PROTEIN TO FAT RATIO ON GLYCAEMIC CONTROL, ENERGY EXPENDITURE AND APPETITE, BEFORE AND AFTER WEIGHT LOSS
T5:P5a-035 CENTRAL OBESITY AND DIURETIC-INDUCED POTASSIUM DEPLETION IN HYPERTENSIVE PATIENTS
Mariosa Lydia, Ribeiro Filho Fernando F, Zanella Maria-Teresa, Ribeiro Artur Federal University of Sao Paulo, Brazil Diuretic therapy is a main cause of hypokalemia in hypertensive patients, but the conditions which predispose to greater potassium (K) depletion are not clear. Methods: In this study, we evaluated 467 hypertensive patients on diuretic therapy, who were classifi ed into two groups according to plasma K levels: ≥ 4 mEq/l (71%) or < 4 mEq/l (29%). All patients were submitted to an oral glucose tolerance test, with plasma glucose values determined at fasting and 2 hour after oral glucose load (2h-plasma glucose). Results: As shown in the table, patients with plasma K < 4 mEq/l were more obese, showed greater waist circumference and higher 2h-plasma glucose than those with K ≥ 4 mEq/l.
31,2 ± 7,5 32,7 ± 7,7 * Waist circumference (cm) 100,8 ± 17,6 104,2 ± 18,2* Systolic/ Diastolic BP (mmHg) 140 ± 19/89 ±12 145 ± 23/90 ±11 Fasting plasma glucose (mg/dl) 93,6 ± 18,3 96,5 ± 19,2 2h-plasma glucose (mg/dl) 125,5 ± 41,5 142,8 ± 56,0* Although hypokalemia may contribute to worsen insulin resistance, our results suggest that central obesity, which is linked to insulin resistance, may predispose to hypokalemia in hypertensive patients during diuretic therapy. Aims: The purposes of this study were to evaluate changes in meal patterns during a comprehensive weight-management program and establish their association with weight loss. Methods: The behavioral 4-month program included dietary therapy, physical activity, and behavior modifi cation, and consisted of 15 weekly group sessions. Data from four 24-h dietary recalls, reviewed for completeness and accuracy by a trained technician, were collected before and after the intervention, and were analyzed for 121 overweight and obese women (BMI, 30.4±3.8 kg/m 2 ). Results: After treatment, subjects increased the total number of meals, namely the number of morning, afternoon, and evening snacks (p<0.05). Breakfast percent caloric intake decreased by 10.7 % (p=0.049), while morning snack percent caloric intake increased by 52.9 % (p<0.001). The proportion of total caloric intake from the main meals (lunch and dinner) decreased by 6.7 % (p=0.049). Using linear regression, change in the number of meals per day was the only variable associated with weight loss (p=0.014); subjects who increased their meal frequency lost the most weight. The predictive positive effect of meal frequency on weight loss was signifi cant when weight loss was compared between successful (more than 5% weight loss) and non-successful participants (p=0.028). Conclusions: Increasing the number of daily meals to promote satiety, dietary control, and weight loss is commonly recommended. The present fi ndings support the use of this strategy in the context of behavioral obesity treatment for women seeking weight management. Aims: The purpose of this research was to evaluate the effects of "About losing weight?", a program ascribing to the Health at Any Size Paradigm (H@AS) on eating behaviors, body image, self-esteem, selfeffi cacy, physical activity involvement and body mass index. The role of decision-making was also examined.
T5:P5a-036 MEAL PATTERNS AND WEIGHT REDUCTION DURING BEHAVIORAL OBESITY TREATMENT IN WOMEN
T5:P5a-037 EFFECT OF A WEIGHT-MANAGEMENT PROGRAM ASCRIBING TO A HEALTH-CENTERED PARADIGM
Methods:
The study used a quasi-experimental design. The intervention was offered to middle-aged, obese women who were chronic dieters (n = 286). The program, which was offered at local community health centers, consisted of four months of weekly health education and group discussions focused on a nondieting approach to weight loss.
Results: The program resulted in signifi cant and sustained improvements in body image, as well as less stable improvements in emotional eating and self-esteem. At 12 months, improvements in dieting, selfeffi cacy, and depression were also observed. There were no signifi cant reductions in body mass index although a greater proportion of persons in the control group increased their weight. Decisional status acted as a moderator in that women in the experimental group who, by the end of the intervention, had made an informed decision about weight loss experienced greater improvements in psychosocial outcomes.
Conclusions:
In the context of a healthy weight-management intervention, women who participate in the program and make an informed decision about weight loss had greater improvements in body image, emotional eating, and bulimic tendencies. Aims: The purpose of this study was to evaluate the effects of monounsaturated fatty acids (MUFA) on energy expenditure. Methods: A total of 24 subjects (12 men and 12 women) with a BMI of 28.15±3.26, age 34.21 ± 7.47 years, ingested a load corresponding to 30% of their BMR as peanut oil in milk shake for 8 weeks. Basal metabolic rate (BMR) and diet-induced thermogenesis (DIT) were measured using indirect calorimetry, at the beginning and at the end of the study, and these were related to lipid profi le. Results: A weight gain was observed; however, this was only 39.16% of the expected weight gain. HDL-C of the volunteers was statistically higher after 8 weeks of the study; however, there was registered an increase (7.50 mg/dL) in the fi rst 4 weeks, followed by a decrease (5.50 mg/dL) up to the 8th week. BMR was also signifi cantly higher after the study, even after correction by weight. No signifi cant differences were observed for DIT, diet composition and physical activity during the study. Conclusions: Monounsaturated fatty acids increase BMR but not alter DIT. Further studies are necessary to evaluate the effects of peanut oil-containing MUFA not in addition to the diet, but as a substitute of saturated fatty acids. Supported by: USAID-LAG-G-00-96-90013-00. University of London, UK Aims: To assess the effect of type and frequency of different types of dietary advice to all adults with type 2 diabetes on morbidity, weight, quality of life, total mortality and measures of diabetic control. Methods: We searched The Cochrane Library, MEDLINE, EM-BASE, CINAHL, AMED, bibliographies and contacted experts. All randomised controlled trials, of six months or longer, where dietary advice was the main intervention in adults with type 2 diabetes mellitus, were included. Results: Thirty-six articles reporting eighteen trials were included. Various dietary approaches were looked at. Nine studies looked at dietary advice versus another diet. Six studies compared dietary advice with dietary advice plus exercise and three other studies looked at dietary advice versus dietary advice plus behavioural approaches. All the studies all measured weight and glycaemic control although not all studies reported these. Other outcomes measured in these studies included mortality, blood pressure, serum cholesterol (including LDL and HDL cholesterol), serum triglycerides, maximal exercise capacity and compliance. Conclusions: Adoption of regular exercise is a good way to promote better glycaemic control in type 2 diabetic patients. There is a need for well-designed studies that examine a range of interventions, although there is one promising study currently underway. Aims: To evaluate the predictive value for fruitfulness of weight loss, and future compliance to the low-calorie diet (LCD) from the results of DR from the previous day before starting the low-calorie diet therapy and to compare results of DR of obese (DRo) with the results of DR of non-obese (DRc). Methods: 81 randomly selected obese females were during their 1 st visit in the obesity treatment centre asked for their DR from the previous day (DRo), as well as their BMI was set. They were recommended to keep LCD (1200 kcal, 20% calories from fat) and were examined (BMI) after 3 months. The control sample was created from age-matched healthy non-obese 250 females. Energy and nutritional content from all DRs were analysed using NutriDAN software. Dependence of BMI reduction upon nutritional results from DRo was investigated using a linear regression model. T-test of DRo between drop-out patients and ongoing patients after 3 months, as well as comparison of DRo with DRc were performed. Results: There was found only a weak negative correlation between total energy intake and reduction of BMI (cor. coef: 0.004, t-stat: 1.93; P-value 0.059). There was no confi rmation of difference in the DR of drop-out patients and ongoing patients. The mean values of energy, protein, fat, carbohydrates and other nutrients reached only 72-77% of the mean values of DRc. Conclusions: We found no evidence that analysis of DR has a signifi cant predictive function for weight loss, probably because of low validity of DR reported by obese persons.
T5:P5a-038 EFFECT OF PEANUT OIL ON METABOLISM AND THERMOGENESIS IN OVERWEIGHT SUBJECTS
T5:P5a-039 DIETARY ADVICE FOR PREVENTION OF TYPE 2 DIABETES MELLITUS IN ADULTS
T5:P5a-041 HAS THE ANALYSIS OF 24-HOUR DIETARY RECALL (DR) PRIOR THE BEGINNING OF THE DIET THERAPY ANY PREDICTIVE VALUE FOR FRUITFULNESS OF WEIGHT LOSS?
T5:P5a-042 OPPOSING EFFECTS OF CALCIUM AND CALORIC INTAKE ON WEIGHT REGAIN AFTER DIET
Ochner Christopher N., Lowe Michael R. Drexel University, Philadelphia, Pennsylvania, USA Aims: The purpose of these analyses was to determine the relationship between calcium and caloric intake (as predictors) and weight regain following a weight-loss diet. Methods: In all, 103 women lost weight (M = 9.6 kg) on a meal replacement-supplemented diet over a 6-month period. Caloric intake and calcium intake were both assessed using the Block Food Frequency Questionnaire at 6 months (post-treatment) and at an 18-month follow up. All treatment ended at 6 months. Using change scores from 6 to 18 months, a regression analysis examined the relationship between changes in calcium and caloric intake and weight change (the outcome variable). Results: When tested individually, neither change in calcium intake nor change in caloric intake was associated with change in weight. However, when entered simultaneously, increases in caloric intake predicted increased weight regain and increases in calcium intake predicted decreased weight regain after the diet. Thus, each variable was predictive in the expected direction only when controlling for the other variable (a dual suppressor effect). Conclusions: Increases in caloric intake produce both greater weight gain and higher calcium intake. However, greater calcium may oppose weight gain, canceling out the effect of higher caloric intake. Therefore, when entered singly, neither variable predicts weight change. However, when holding the other variable constant, a positive relationship between caloric intake and weight gain, as well as a negative relationship between calcium intake and weight gain, is revealed.
T5:P5a-043 COST EFFECTIVENESS OF MEAL REPLACEMENT PRODUCTS IN WEIGHT CONTROL
O'Reilly Jacqueline , Carr Louise, West Peter York Health Economics Consortium, University of York, UK Aims: In a recent trial, GPs' patients did not achieve weight loss through diet and lifestyle modifi cations alone, which suggests that additional weight management tools are necessary (Moore et al., BMJ 2003; 327) . This paper conducts an economic evaluation of partial meal replacements (PMRs), compared to the anti-obesity pharmaceutical agent, orlistat. Methods: The study examined the cost and effi cacy of PMRs compared to orlistat using cost utility and cost effectiveness models. The perspective of the study was that of the UK National Health Service (NHS). Data from published sources were used to populate a Markov model, estimating the costs and benefi ts of the two treatments for 1,000 patients over 1 year. Two scenarios were examined. The fi rst assumed that NHS resource utilisation for a PMR regime was similar to that of a traditional reduced-calorie diet. The second scenario involved minimal medical input for PMR -one initial GP visit prior to commencing treatment. Results: PMRs yielded slightly better results than orlistat in weight loss (74% of PMR subjects lost ≥ 5% of initial body weight compared to 53% of orlistat), improvements in quality-adjusted life years (0.0066) and the impact of weight on quality of life score (0.8). Of more significance was the cost difference: PMR was less costly than orlistat in both scenarios (resulting in savings of over £500 per patient over 1 year). Conclusions: Under the assumptions and data in this study, PMRs were found to be cost-effective relative to orlistat for weight loss, making them a potentially worthwhile programme for consideration by GPs.
T5:P5a-044 THE ROLE OF ENERGY EXPENDITURE PREDICTION EQUATIONS IN A WEIGHT MANAGEMENT CLINIC
O'Riordan Christina, Metcalf Brad, Alba Sandra, Noble Louise, Perkins Jenny, Wilkin Terence Peninsula Medical School, Plymouth, UK Aims: The national obesity forum recommends a "500kcal defi cit of energy requirements" to achieve appropriate weight loss in the overweight and the obese. We compared four energy expenditure prediction equations with measured resting energy expenditure (REE) by indirect calorimetry (IC) across a range of BMI, in order to evaluate their predictive value for individuals attending a weight management clinic. Methods: IC was used to measure REE in 196 adults (28 male, 168 female, mean age 28.9 ± 6.4.yrs) with a BMI ranging from 19 to 67kg/m 2 . REE was calculated using the Schofi eld (S, 1985), Harris & Benedict (H &B, 1919) , James and Lean (J&L, 1986) and WHO (1985) energy expenditure prediction equations. Results: The mean REE by IC, S, H&B, J&L and WHO were 1934 J&L and WHO were , 1983 J&L and WHO were , 1933 J&L and WHO were , 2001 and 1966 kcals/day, respectively. Paired t-tests between methods demonstrated signifi cant differences between IC and S (p=0.034) and IC and J&L (p=0.003). An increasing BMI had only a slight effect on the difference between IC and S (+65kcals/10 units BMI, p=0.02). However, the variance was large and the estimated REE in an individual with a BMI of 35 could lie anywhere from 661kcals above the IC measure to 618kcals below it. Individual precision was not better for the other equations: J&L 67 ± 634 kcals, H&B 1± 584kcals, WHO 32± 614kcals. Conclusion: Prediction equations offer a quick assessment of energy requirements needed for hypocaloric diets. In reality, however, they run the risk of randomly offering excessive restriction or weight-gaining programmes. Dietetics is a science and its successful practice demands reliable tools.
T5:P5a-045 EFFECTS OF ENCAPSULATED GREEN TEA EXTRACT AND CAFFEINE ON 24H ENERGY EXPENDITURE AND FAT OXIDATION IN MEN
Pelletier Catherine, Bérubé-Parent Sonia, Tremblay Angelo Division of Kinesiology, Laval University, Québec, Canada Aims: It has been reported that green tea has a thermogenic effect, due to its caffeine content, and probably also to the catechin epigallocatechin-3-gallate (EGCG). The main aim of this study was to compare the effect of green tea extract containing a fi xed dose of caffeine and variable doses of EGCG on 24h energy expenditure and fat oxidation. Methods: Fourteen subjects took part in this randomized, placebo-controlled, double-blind, crossover study. Each subject was tested 5 times in a metabolic chamber to measure 24h energy expenditure, substrate oxidation and blood pressure. During each stay, the subjects ingested a placebo or capsules containing 200 mg of caffeine and a variable dose of EGCG (90, 200, 300 or 400 mg) 3 times/day, 30 minutes before controlled meals. All subjects received the 5 doses and treatment order was randomized. Results: The 24h energy expenditure increased signifi cantly by about 750 kJ with any dose of EGCG compared to placebo. No effect of the green tea extract was observed for lipid oxidation. Systolic and diastolic blood pressure increased by 6-9 and 4-6 mmHg, respectively, with EGCG compared to placebo. This increase was signifi cant only for 24h diastolic blood pressure.
Conclusions:
The main fi nding of this study was the increase in 24h energy expenditure with the green tea extract. However, this increase was similar with all doses of EGCG. Aims: The incidence of obesity is increasing in modern society. Most physicians treat the consequences of obesity (i.e. diabetes, hypertension), but may fail to address obesity for many reasons. The aim of this study is to assess the possibility of a combined approach for the treatment of obesity and healthy-weight maintainance within the primary care setting. Methods: Obese patients (Body Mass Index (BMI) >30) visiting the public Medical Offi ce of Hersonissos were recruited after consenting to participate in the project. All patients gave a detailed medical history, received complete physical examination and blood tests including cholesterol and thyroid function tests. Orlistat with specifi c dietary instructions were administered to the patients. Patients had weekly courses of group therapy, which included measurement of their weight, and were encouraged to continue their efforts. Results: Thirty fi ve obese patients (all women) were recruited, their mean age ranged from 17 to 60 years (mean 42 years). Baseline weight of subjects averaged 85 ±15 kg. BMI at baseline was 33±3 kg/m2. The comorbid conditions at baseline included low back pain (8/35), hypercholesterolemia (7/35), hypertension (5/35), type II diabetes (3/35). Thirty patients completing 3 months in this program lost an average of 4.5 Kg. For 27 patients who completed 6 months, the weight loss continued, with an average loss of 8.5 Kg from baseline weight. For 23 patients who completed 9 months, the weight loss was 11.3 kg. The above patients reported a high degree of satisfaction and agreed that the group therapy sessions were very helpful. No major side effects from the use of orlistat were observed. Conclusion: Primary health care physicians are in a unique position to reach all segments of a population, and therefore can provide a stable offi ce-based approach for weight management and disease prevention. Effective weight management includes pharmacological treatment combined with group therapy techniques. The latter permits a more frequent examination of patient weight, and provides a physician-aided support system for the obese people.
T5:P5a-047 THE ESTIMATION OF EFFECTIVENESS OF DIET FOR PATIENTS SUFFERING FROM OBESITY
Pogozheva Alla V., Denissova Natalia N., Baturin Alexander K. The Institute of Nutrition, Moscow, Russia Aims: To confi rm the effectiveness of dietary treatment for patients with cardiovascular diseas`es under the condition of obesity, for further development of an adequate individual diet. Methods: We have examined 140 patients with obesity aged from 32 to 70 years. Within the framework of the comprehensive clinical examination of the patients, we have made the estimation of anthropometric data and body composition by bioimpedansmetry. To fi x the individual energy expenditures, we used an accelorometre "Caltrac". Food frequency was used for dietary assessment. Results: Before treatment, the average diet energy value was 2409±142,2 kcal for men, calorie burned -2217±141,8 kcal, including 519± 48,3 kcal-owing to motions; for women, it was 2209±132,2 kcal, energy spent -2016±114,1 kcal, including 489±36,3 kcal-owing to motions. The fat content was 45,6% of energy. In clinical conditions, the patients consumed a diet of about 1700 kcal (fat -30 % of energy). The calorie burned was 2100 kcal per day. Simultaneously, patients were trained to principles of a healthy nutrition. In 30 days, the body weight has decreased by 4.6 kg, including 2.3 kg of fat mass. Conclusion: The effectiveness of dietary treatment for patients with obesity must be many-sided and include anthropometric data and the estimation of physical conditions, data physical activity and data on an actual consumption of the patients. Aims: The aim of this study was to examine factors associated with successful weight loss in new members attending a commercial slimming group, Slimming World (SW). Methods: 240 new Slimming World members completed two self-administered questionnaires, one at baseline and one 12 weeks later. These collected personal details and information relating to previous weight loss, dieting experience, eating behaviour, motivation, self-effi cacy, and lifestyle. Weight loss and group attendance was obtained from SW records.
Results: The average age of participants was 40yr and BMI = 31.5kg/m 2 . 95% were female. Mean weight loss over the 12 weeks was 4.8kg (6% weight loss). 54% achieved > 5% weight loss, with 15% achieving >10% loss. The mean attendance was 9.7 weeks. 63% were still attending at 12 weeks; of these, the average attendance was 11 weeks and weight loss 6.2kg (7.3%). Weight loss was positively associated with duration of attendance, smoking, ease of adherence to the dietary plan, early weight loss and self-effi cacy. Members who were economically inactive and those receiving family support were likely to stay in the programme for longer. Other demographic and lifestyle factors were not predictive of success. Conclusions: Targets for 5-10% weight loss for health improvement can be achieved in commercial slimming groups. Compliance to the slimming plan coupled with early weight-loss success and family support seem to be the key elements in achieving success in a commercial setting.
T5:P5a-049 COMBINATION WEIGHT-LOSS THERAPIES FOR TYPE 2 DIABETES MELLITUS
Raatz Susan K., Redmon J. Bruce, Reck Kristell P., Swanson Joyce E., Kwong Christine A., Thomas William, Bantle John P. University of Minnesota, Minneapolis, MN, USA Aims: To evaluate the effects over 2 years of a combination weightloss program on weight loss, diabetes control and cardiovascular risk factors in overweight or obese subjects with type 2 diabetes. We hypothesized that long-term effi cacy of weight-loss therapies would be increased if several weight-loss approaches are combined. Methods: A total of 59 subjects treated with diet or oral medication were randomly assigned to either combination therapy (CT) for 2 years or a standard therapy (ST) for 1 year, followed by a CT in the second year (S/C). All participants received diet, exercise and behavioral instruction as ST. CT consisted of ST plus daily sibutramine; low-calorie diets (LCD) using meal replacements 1 week every 2 months; and, between LCD weeks, once daily use of meal replacements. The outcome measures were body weight, glycemic control, plasma lipids, blood pressure, and body composition. Results: In all, 48 participants (23 CT and 25 S/C) completed 2 years. Both groups had signifi cant weight loss from baseline (4.6 ± 1.2 kg CT and 8.1 ± 1.6 kg S/C, P = 0.08). At 2 years, the change in hgb A1c from baseline was −0.5 ± 0.3% CT and −0.3 ± 0.2% S/C (P = 0.61). However, the average reduction in hgb A1c over 2 years was signifi cantly greater for the CT (0.8 ± 0.1% vs 0.2 ± 0.1% CTand S/C, respectively; P = 0.009). At 2 years, CT had signifi cant reductions from baseline in weight, BMI, fat mass, lean body mass and SBP. Conclusions: Use of a combination of weight loss therapies resulted in signifi cant weight loss and improved diabetes control over a 2-year period in subjects with type 2 diabetes. Aims: Obesity has increased in the world rapidly with epidemic tendency. We present the need for alternative, integral & more effective methods. Method: A group of 190 patients between 25 and 60 years old of both sexes, which initially presented an obesity BMI of 30 to 55.76 with abdominal visceral obesity and fi nally reached BMI under 25, was studied. All were included in a therapeutic, ambulatory, integrated and intensive program. The task is to reach the ideal weight ± 5 kg (adequate weight). Immediate weight loss based on a nutritional scheme VLCD-SMR (Structured Meal Replacement) between 600 and 800 cal., alternating with a period of LCD and therapeutic groups (cognitive behavioural therapy) were applied to approach the Dependant Addictive Link concept. It emphasizes the importance of the small servings, adequate distance between each ingestion and the permanent idea of the quick cut in the loss of control. Adapted Physical Activity and telephone follow-up were used to strengthen the Maintenance Protection Network. Aims: To examine the amount of weight loss required to improve insulin sensitivity in obese children. Methods: We studied changes in insulin sensitivity indices of glucose metabolism (ISI-HOMA, ISI-QUICKI) and fat metabolism (ISI-FFA) over a 1-year period in 57 obese children aged 6 to 14 years, who attended an obesity intervention program. The children were divided into 4 groups according to their changes in standard deviation scores of BMI (SDS-BMI): group I: decrease in SDS-BMI >0.5; group II: decrease in SDS-BMI >0.25 -<0.5; group III: decrease in SDS-BMI <0.25 group IV: increase in SDS-BMI Results: The groups did not differ with respect to age, gender, SDS-BMI or insulin sensitivity indices at baseline. Conclusions: An increase in weight in obese children over a time period of 1 year was associated with a decrease in insulin sensitivity. Weight loss was followed by a signifi cant improvement in insulin sensitivity in glucose and fat metabolism, but only if the SDS-BMI decreased by at least 0.5. Aims: Overweight and obesity have been frequently followed by the increase of comorbidity incidence that contributes a greater risk for the onset and development of atherosclerotic diseases. Obesity therapy may improve signifi cantly the level of arterial hypertension, glycemia and dyslipidemia. Methods: During 6 months, dietary scheme according to "Step One" AHA recommendations was applied to the group of 238 overweight and obese patients. Daily calorie intake was reduced for 400 kcal less than the assessed daily energetic need for every single patient, and the intake of nonstarch polysaccharides was of up to 20 g a day. At the onset of the study and every 30 days, during the investigation period, the nutritional status of patients was estimated by antropometric (body weight, BMI, % of body fat) methods. At the same time at the beginning, after 3 and after 6 months, the following laboratory tests were performed: total serum cholesterol, SCh-HDL and SCh-LDL fractions, triglycerides, glycemia -by standard laboratory methods. Results: BMI values were signifi cantly lower after 3 and 6 months (p<0.001), comparing to initial values. A signifi cant decrease in total cholesterol (p<0.01), SCh-LDL (0.01), and triglyceride levels (0.01) was observed. Values of HDL fraction did not change signifi cantly. Hyperglycemia improved signifi cantly (p<0.04). Conclusions: Dietotherapy makes an important obesity treatment modality, but, at the same time, it is also a method of prevention and treatment of comorbidity, especially in patients who are not treated by drug therapy. Signifi cant decrease in body fat proved to be important regulatory method for treatment of hyperglycemia and dyslipidemia.
The aim of the study was to assess the relationship between weight reduction, good control of hypertension and regression of left ventricular hypertrophy (LVH) in hypertensive and obese patients (P), knowing the involvement of the two characteristics in the pathogenesis of LVH. In all, 34 hypertensive P in II-III stage (20 male Aims: To assess the effects of dietary calcium supplementation on body and tissue weights. To get insight into the mechanism of action of calcium. Methods: Experiment (1) Five-week-old male mice (C57BL/6J) have been fed with a high-fat diet (43%) (group C, control) or with this diet supplemented with calcium (12g/kg) (group Ca, calcium) during 2 months. Experiment (2) Five-week-old male mice (C57BL/6J) have been fed with a high-fat diet (43%) during 3 months to make them obese. Then, animals have been fed with a low-fat diet (12%) or with this low-fat diet supplemented with calcium (12 g/kg) for one month.
Results: During the period of high-fat feeding, animals supplemented with calcium (Ca group) showed a lower rate of body weight gain. At the end of experiment I, body weight in group Ca was 10.3% lower than in group C. Interestingly, liver and kidney weights were not affected but all adipose tissue weights were reduced. In white depots, the range was from 34% (mesenteric) to 69% (retroperitoneal) and in brown fat was decreased by 48%. UCP1 levels were slightly decreased in the Ca group. In experiment II, removal of high-fat diet was accompanied by a faster decrease in body weight in the calciumsupplemented group. Conclusions: Dietary calcium supplementation helps to counteract obesity during either a gaining-weight phase or a slimming phase. The molecular mechanism involved is being investigated. Aim: Airline personnel work irregular working hours. Alertness plays a signifi cant role in achieving high-quality customer service and air safety. A questionnaire concerning self-perceived work ability during the next two years is a strong predictor of future absenteeism from work and early retirement. The aim was to assess the determinants of self-perceived work ability. Methods: Previously validated questionnaires inquiring items on lifestyle (body mass index, alcohol consumption, smoking, exercise habits), sleep disturbances (sleep apnea, sleep disorder, daytime sleepiness, insuffi cient sleep), work-related stress, depression and self-experienced disability due to musculoskeletal problems were used. The subjects included 230 individuals in various airline professions. Discriminant analysis was used to assess the differences between those who considered themselves able to work and those who were concerned about their ability to continue working.
Results: 8,9 % of the study sample reported uncertainty concerning work ability.
Conclusions: Those who report uncertainty concerning self-perceived work ability suffer from multiple problems including weight management, sleep, alertness, musculoskeletal and psychological elements.
T5:P5a-066 THE EFFECT OF HYPOENERGETIC DIETS WITH A FAT ENERGY PERCENT OF 20-25 OR 40-45 ON BODY WEIGHT, BLOOD LIPIDS, INSULIN AND GLUCOSE IN COMPILANT OBESE SUB
The NUGENOB Consortium Represented by Martin Petersen and Moira A Taylor Aims: To study the effect of low-and moderate-fat diets on weight loss, blood lipids, insulin and glucose in compliant obese subjects. Methods: Obese subjects (n=771) were randomised to a 10-week dietary intervention comparing two hypoenergetic diets with a fat E% of 20-25 or 40-45, only data from compliant subjects are reported here, n=154 and n=136 resp. Results: The energy intake was 1519 ± 333 kcal/d (mean ± SD) in the low-versus 1613 ± 319 kcal/d in the moderate-fat group, p=0.05. Weight loss was 7.2 ± 3.1 kg in the low versus 6.8 ± 3.3 kg in the moderate-fat group (ns). Fasting plasma total, LDL, and HDL-cholesterol decreased in both groups, for HDL more so in the low-fat group, 0.11 ± 0.18 versus 0.04 ± 0.18 mmol/l (p=0.002). Plasma triacylglycerol was lowered by 0.23 ± 0.63 mmol/l in the moderate-fat group, but was unchanged in the low-fat group (p<0.001, group diff.). Both diets lowered plasma insulin and glucose, with a tendency to a higher reduction in the moderate fat diet (p=0.05, p=0.08) resp. Conclusions: In compliant obese subjects, the diets were equally effective in promoting a weight loss. Both groups had favourable changes in fasting blood lipids, insulin and glucose; the moderate-fat diet had more beneficial effects on plasma triacylglycerol and HDL-cholesterol. -2000-00618 Aim: To investigate the effect on maintenance of a major low-calorie diet (LCD), induced body weight (BW) and fat mass (FM) loss in healthy overweight or obese volunteers of 1 year daily intake of 3.4 g CLA free fatty acid (CLA-FFA) in an equal mixture of c9,t11& c10,t12 (Tonalin) Methods: A total of 101 (57 females) obese (age 43 ± 8y, BMI 32 ± 2 kg/m 2 ) healthy subjects were, after 8-week LCD, induced weight and fat losses of 10 and 7 kg, respectively, randomized to a 1-year doubleblinded placebo (olive oil)-controlled CLA-FFA (n=51) supplementation. Subjects were instructed to follow a modest hypocaloric diet of -300 kcal based on WHO equations including body weight, gender and age. The two groups were well matched. Body composition was assessed by DEXA scan. Results: Data on all subjects who completed ½ year treatment were analyzed by ITT. The CLA-FFA group (n=40) had regained 3.1 ± 5.3 kg BW and 2.1 ± 5.0 kg FM compared with 3.0 ± 5.1 kg and 2.5 ± 5.1 kg in the placebo group (n=43) (group difference NS). There were no group differences in reported adverse effects. Conclusions: One-year 3.4 g daily CLA (c9, t11 & c10, t12) supplementation does not prevent weight or fat regain after an LCD-induced major weight loss in a healthy obese population. This study was sponsored by Natural ASA, Lysaker, Norway.
NUGENOB: Nutrient-gene interactions in human obesity -implications for dietary guidelines, www.nugenob.com supported by EU (QLRT
T5:P5a-068 THE IMPORTANCE OF HYPOCALORICAL DIET AND LONG-TERM PHYSICAL EXERCISE IN THE MANAGEMENT OF OBESITY
Tudor Constantin, Vizman Carmen, Tatar Kinga, Lungu Valeriu, Jeberean Aurora U.M.F. "Victor Babes", Timisoara, Romania Introduction: Obesity, during its evolution, associates with many cardiorespiratory and metabolic complications, reducing considerably the life expectation of the obese patient. The metabolic disorders that occur represent risk factors, which could enhance the risk of cardiovascular events. Aims: To establish a method of weight loss using hypocaloric diet and long-term physical exercise. Methods: The study included 180 obese patients who adopted hypocaloric diet and long-term physical exercise according to their osteoarticular and cardiorespiratory performance, using two different programs: I. 90 obese patients with a BMI~36.4 kg/m 2 and waist circumference M~98.3 cm, F~92.2 cm, were treated in the clinic using a diet of 500 kcal/ day and physical exercise supervised by a specialized trainer. II. 90 obese patients with a BMI~36.2 kg/m 2 and waist circumference M~98.2 cm and F~ 91.8 cm were treated at home, using a diet of 1200 Kcal/day and behavioral therapy. Results: In the clinic, the average weight loss ranged between 2.3 ± 0.8 kg/ week and in the home-treated group between 2.5 ± 0.4 kg/month by using the hypocaloric diet based on vegetables, fruits and fi bers (p<0.001).
Conclusions:
The results show that the treatment of obesity should be initiated in the clinic and continued at home under medical surveillance to prevent further weight gain.
